Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Not Yet Recruiting NCT05733559

QIAstat-Dx® Respiratory Panel Plus (RPP) Clinical Performance Study

Conditions: Respiratory Disease

Sex: All
Enrollment: 500
Sponsor: QIAGEN Gaithersburg, Inc

Summary

This study will evaluate the clinical performance of the QIAstat-Dx® Respiratory Panel Plus (RPP) SARS-CoV-2 target with a validated comparator method

Eligibility Criteria

Inclusion Criteria:Presenting with signs and symptoms of a respiratory infection.Consent or assent to be obtainedAble to communicate (speak, read and write) in local language, and able to understand and sign the required study documents.Willing and able to provide Nasopharyngeal Swab (NPS) Specimen collected per manufacturer's instructions.Exclusion Criteria:Subjects who, in the opinion of the Investigator, are unsuitable for participation in the study.

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05733559). StuddyBuddy aggregates publicly available trial information.